Ensysce Biosciences, Inc. (ENSC)
Pharmaceutical Preparations
Latest Price
$0.49
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
0.56
P/B Ratio
0.88
Institutional Ownership
5.4% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| JANE STREET GROUP, LLC | 208.8K | -- | 1.29% | +195.3K | 2026-06-30 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 149.7K | -- | 0.92% | -- | 2026-06-30 |
| Virtu Financial LLC | 95.4K | -- | 0.59% | +82.1K | 2026-06-30 |
| PERCEPTIVE ADVISORS LLC | 86.7K | -- | 0.53% | -- | 2026-06-30 |
| CITADEL ADVISORS LLC | 86.2K | -- | 0.53% | +28.8K | 2026-06-30 |
| XTX Topco Ltd | 77.0K | -- | 0.47% | +52.6K | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 62.2K | -- | 0.38% | -11.7K | 2026-06-30 |
| HRT FINANCIAL LP | 54.4K | -- | 0.34% | +29.9K | 2026-06-30 |
| TRU INDEPENDENCE ASSET MANAGEMENT 2, LLC | 13.0K | -- | 0.08% | -- | 2026-06-30 |
| TWO SIGMA SECURITIES, LLC | 13.0K | -- | 0.08% | -- | 2026-06-30 |